Theriva Biologics's total assets for Q2 2025 were $35.83M, an increase of 11.41% from the previous quarter. TOVX total liabilities were $25.21M for the fiscal quarter, a 51.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.